Foster & Motley’s Prestige Consumer Healthcare PBH Stock Holding History

Foster & Motley’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,733	Closed	-$218K	–	398
2025 Q2	$218K	Hold	2,733	–	–	0.01%	377
2025 Q1	$235K	Sell	2,733 -350	-11%	-$28.7K	0.01%	358
2024 Q4	$241K	Hold	3,083	–	–	0.02%	351
2024 Q3	$222K	Sell	3,083 -389	-11%	-$27.5K	0.01%	365
2024 Q2	$239K	Sell	3,472 -422	-11%	-$28.6K	0.02%	356
2024 Q1	$283K	Sell	3,894 -179	-4%	-$12K	0.02%	339
2023 Q4	$249K	Buy	+4,073	New	+$242K	0.02%	358
2023 Q3	–	Sell	-4,122	Closed	-$245K	–	377
2023 Q2	$245K	Buy	+4,122	New	+$247K	0.02%	358
2022 Q3	–	Sell	-4,084	Closed	-$240K	–	354
2022 Q2	$240K	Sell	4,084 -321	-7%	-$17.7K	0.02%	327
2022 Q1	$233K	Hold	4,405	–	–	0.02%	337
2021 Q4	$267K	Buy	+4,405	New	+$262K	0.02%	320

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Foster & Motley's PBH Position: Q3 2025 in Review

Foster & Motley sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 2,733 shares — an estimated $218K sold.

Foster & Motley first reported a position in PBH in Q4 2021 and held it in 11 quarters. The position peaked at $283K in Q1 2024. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

Foster & Motley reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
Foster & Motley sold 2,733 Prestige Consumer Healthcare shares in Q3 2025, an estimated $218K.
Foster & Motley first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 11 quarters.
Foster & Motley's Prestige Consumer Healthcare position peaked at $283K in Q1 2024.
356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Foster & Motley's 13F filing for Q3 2025, filed 23 Oct 2025.